REQUEST A DEMO
Total
USD $0.00
Search more companies

Softdeal Pharmaceutical Private Limited (India)

Main Activities: Drugs and Druggists' Sundries Merchant Wholesalers
Full name: Softdeal Pharmaceutical Private Limited Profile Updated: August 16, 2024
Buy our report for this company USD 29.95 Most recent financial data: 2023 Available in: English Download a sample report

Softdeal Pharmaceutical Private Limited is an unlisted company, incorporated on 25/01/2006. It has its registered office in the State of Maharashtra, India. Company's corporate identification number (CIN) is U51900MH2006PTC159237 and registration number is 159237. The company is a trade company, it is engaged in wholesale trading.

Legal Address
Acme Plaza, Andheri - Kurla Road Andheri (East)
Mumbai; Maharashtra; Postal Code: 400059

Contact Details: Purchase the Softdeal Pharmaceutical Private Limited report to view the information.

Basic Information
Total Employees:
Purchase the Softdeal Pharmaceutical Private Limited report to view the information.
Outstanding Shares:
Purchase the Softdeal Pharmaceutical Private Limited report to view the information.
Registered Capital:
Purchase the Softdeal Pharmaceutical Private Limited report to view the information.
Incorporation Date:
January 25, 2006
Key Executives
Purchase this report to view the information.
Additional Executive Director
Purchase this report to view the information.
Professional Director
Purchase this report to view the information.
Professional Director
Ownership Details
Purchase this report to view the information.
100%
Company Performance
Financial values in the chart are available after Softdeal Pharmaceutical Private Limited report is purchased.
Looking for more than just a company report?

EMIS company profiles are part of a larger information service which combines company, industry and country data and analysis for over 145 emerging markets.

Request a demo of the EMIS service
Key Financial Highlights
Annual growth percentages for latest two years in local currency INR. Absolute financial data is included in the purchased report.
Net sales revenue
-14.71%
Total operating revenue
-13.53%
Operating profit (EBIT)
-6.96%
EBITDA
-6.92%
Net Profit (Loss) for the Period
-7.16%
Total assets
24.84%
Total equity
90.81%
Operating Profit Margin (ROS)
2.14%
Net Profit Margin
1.55%
Return on Equity (ROE)
-50.2%
Quick Ratio
1%
Cash Ratio
-0.01%

To view more information, Request a demonstration of the EMIS service

Buy this company report
Need ongoing access to company, industry or country information?